GZ
Greg Zante sold $710K of VKTX stock
Greg Zante, Chief Financial Officer of Viking Therapeutics, Inc. (VKTX), sold 21,217 shares of VKTX stock worth $710K, per an SEC Form 4 filed Jul 30, 2026.
It was an open-market sale.
The trade happened on Jul 28, 2026, 2 days before it was made public.
VKTX has moved -22.7% since the trade date, from $33.86 to $26.17 (Nov 18, 2026 close).
- Traded
- Jul 28, 2026
- Disclosed
- Jul 30, 2026
- Filing delay
- 2 days
- Price since
- -22.7%
- Role
- Chief Financial Officer
- Source
- SEC Form 4